Literature DB >> 4092

31P nuclear magnetic resonance study of alkaline phosphatase: the role of inorganic phosphate in limiting the enzyme turnover rate at alkaline pH.

W E Hull, S E Halford, H Gutfreund, B D Sykes.   

Abstract

31P nuclear magnetic resonance (NMR) was used to directly observe the binding of inorganic phosphate to alkaline phosphatase. Evidencq for the tight binding of 1.5-2.0 mol of inorganic phosphate per dimer of alkaline phosphatase is presented. Two distinct forms of bound phosphate are observed, one predominating above pH 7 and representing the non-covalent E-P1 complex and the other predominating below pH 5 and representing the covalent E-P1 complex. The 31P NMR line width of the E-P1 complex indicates that the dissociation of noncovalent phosphate is the rate-limiting step in the turnover of the enzyme at high pH.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4092     DOI: 10.1021/bi00652a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.

Authors:  Shay Eliahu; Haim M Barr; Jean Camden; Gary A Weisman; Bilha Fischer
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

2.  2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.

Authors:  Shay Eliahu; Alba Martín-Gil; María Jesús Perez de Lara; Jesús Pintor; Jean Camden; Gary A Weisman; Joanna Lecka; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

3.  Structural studies of human alkaline phosphatase in complex with strontium: implication for its secondary effect in bones.

Authors:  Paola Llinas; Michel Masella; Torgny Stigbrand; André Ménez; Enrico A Stura; Marie Hélène Le Du
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

4.  Sensitive fluorogenic substrate for alkaline phosphatase.

Authors:  Michael N Levine; Ronald T Raines
Journal:  Anal Biochem       Date:  2011-07-24       Impact factor: 3.365

5.  Distinct structure and activity recoveries reveal differences in metal binding between mammalian and Escherichia coli alkaline phosphatases.

Authors:  Le Zhang; René Buchet; Gérard Azzar
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

6.  The inhibition and disposition of intestinal alkaline phosphatase.

Authors:  K W Gasser; L B Kirschner
Journal:  J Comp Physiol B       Date:  1987       Impact factor: 2.200

7.  The relationship between the optical properties and the kinetic behaviour of ascorbate-inhibited alkaline phosphatase.

Authors:  G E Martorana; E Meucci; A Ursitti; G A Miggiano; A Mordente; A Castelli
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

8.  The pH-dependent activation mechanism of Ser102 in Escherichia coli alkaline phosphatase: a theoretical study.

Authors:  Hao Zhang; Ling Yang; Wanjian Ding; Yingying Ma
Journal:  J Biol Inorg Chem       Date:  2017-12-30       Impact factor: 3.358

9.  Differentiation of the slow-binding mechanism for magnesium ion activation and zinc ion inhibition of human placental alkaline phosphatase.

Authors:  H C Hung; G G Chang
Journal:  Protein Sci       Date:  2001-01       Impact factor: 6.725

10.  Kinetics and crystal structure of a mutant Escherichia coli alkaline phosphatase (Asp-369-->Asn): a mechanism involving one zinc per active site.

Authors:  T T Tibbitts; X Xu; E R Kantrowitz
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.